Tax

Stock-Based Compensation Tax Benefit

Medtronic Stock-Based Compensation Tax Benefit decreased by 37.9% to $18.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 5.9%, from $17.00M to $18.00M. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementIncome Statement
SectionTax
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2018
Last reportedQ3 2026Feb 24, 2026

How to read this metric

An increase indicates higher tax efficiency related to compensation, often correlated with higher stock-based expense.

Detailed definition

The income tax benefit recognized in the financial statements resulting from the tax deductibility of share-based compen...

Peer comparison

Standard tax reconciliation item for companies with significant equity compensation.

Metric ID: cat_sbc_tax_benefit

Historical Data

15 periods
 Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26Q2 '26Q3 '26
Value$11.00M$26.00M$13.00M$11.00M$26.00M$14.00M$11.00M$25.00M$14.00M$13.00M$25.00M$17.00M$15.00M$29.00M$18.00M
QoQ Change+136.4%-50.0%-15.4%+136.4%-46.2%-21.4%+127.3%-44.0%-7.1%+92.3%-32.0%-11.8%+93.3%-37.9%
YoY Change+0.0%+0.0%+7.7%+0.0%-3.8%+0.0%+18.2%+0.0%+21.4%+15.4%+16.0%+5.9%
Range$11.00M$29.00M
CAGR+15.1%
Avg YoY Growth+6.7%
Median YoY Growth+2.9%

Stock-Based Compensation Tax Benefit at Other Companies

Frequently Asked Questions

What is Medtronic's stock-based compensation tax benefit?
Medtronic (MDT) reported stock-based compensation tax benefit of $18.00M in Q4 2025.
How has Medtronic's stock-based compensation tax benefit changed year-over-year?
Medtronic's stock-based compensation tax benefit increased by 5.9% year-over-year, from $17.00M to $18.00M.
What does stock-based compensation tax benefit mean?
The tax savings generated by the company's stock-based compensation programs.